PELNSEPiramal Enterprises Limited· PharmaceuticalsLowNeutral
Announced Mon, 30 Jun · 22:41 IST

Piramal Enterprises Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on June 30, 2025. Further, the company has submitted the Exchange a copy of Srutinizers report and Voting Results in Regulation 44(3).

Board & Shareholder Meetings View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Piramal Enterprises held its 78th AGM on June 30, 2025 via video conferencing, chaired by Mr. Ajay G. Piramal. All 13 resolutions were passed with the required majority, including adoption of FY25 audited financial statements and a final dividend of Rs. 11 per equity share (on face value of Rs. 2). The meeting also approved the re-appointment of directors Ms. Nandini Piramal and Ms. Shikha Sharma, appointment of N. M. Raiji & Co. and Chhajed & Doshi as joint statutory auditors, re-appointment of independent directors Mr. Suhail Nathani, Mr. Kunal Bahl, and Ms. Anjali Bansal, and continuation of Mr. Ajay Piramal as Chairman beyond age 70. Two special business items were cleared: issuance of non-convertible debentures on a private placement basis and a provision to convert loans into equity in case of a default event. Voting was largely supportive, though public institutions showed notable dissent on the Ajay Piramal continuation (20.5% against) and the Suhail Nathani re-appointment (29.4% against).

Likely market impact

Shareholders are set to receive a Rs. 11 final dividend per share for FY25, with all key governance proposals cleared without disruption. The dissenting votes on the Chairman's continuation and one independent director re-appointment signal some institutional discomfort but did not affect the outcomes, so the overall impact on shareholders is neutral to mildly positive.